Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIF5C | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
mRNA | ZNF292 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | DCHS1 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-09 |
mRNA | ZNF559-ZNF177 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | KMT5C | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | IDH2 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | DAP3 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-09 |
mRNA | UNC5A | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |
mRNA | ZNF3 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
mRNA | TMSB15B | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |